Experimental mRNA vaccine cuts risk melanoma returns by 42%
The results are an important advance for the treatment of melanoma, oncologists said, because patients lived significantly longer without their cancer returning.
16 across the spectrum. Choose a side on the bar to jump to it.
National story. 17 articles from 17 sources. 16 are on the bar; 1 is an international, entertainment or tech outlet, listed separately. Updated 36m ago.
Left
4 sourcesHere’s what Moderna’s latest mRNA cancer vaccine data actually show
A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial
Center
11 sourcesNovel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
STAT+: Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial
Right
1 sourceFirst-of-its-kind cancer vaccine helps reduce chances of melanoma patients’ tumors returning: study
Other outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
1 article‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows
Center
0 articlesNone
Right
0 articlesNone